By bridging materials science, engineering, and clinical oncology, hydrogel-assisted strategies offer a roadmap toward personalized, multifunctional, and patient-centered cervical cancer therapy, addressing persistent limitations of conventional brachytherapy and enabling next-generation biomaterial-driven oncologic interventions
Also in the pipeline is retatrutide , a triple agonist that activates GLP-1, GIP, and glucagon receptors
Incorrect Dosing and Side Effects Without baseline metabolic data: Dosing may be too aggressive Side effects (nausea, fatigue) may be exacerbated False Sense of Safety The logic often goes: If its FDA-approved, it must be safe for me. But FDA approval assumes appropriate patient selection and monitoringnot universal applicability without evaluation
Polypharmacy concerns are more prominent in elderly patients
and Solberg, H.E